Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

MBRXMBRX
2 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in MOLECULIN BIOTECH INC

CITADEL ADVISORS LLC previously held 0 shares of MBRX (MOLECULIN BIOTECH INC), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$109,511

Total Shares Change

-33,085

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$2.27
0
2025-Q4
New
33,085
-
$109,5110.0%$3.32
33

Other major holders of MBRX: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used